Next Article in Journal
Natural Killer Cell-Mediated Immunotherapy for Leukemia
Next Article in Special Issue
Innate Immune Program in Formation of Tumor-Initiating Cells from Cells-of-Origin of Breast, Prostate, and Ovarian Cancers
Previous Article in Journal
Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
 
 
Article

Article Versions Notes

Cancers 2022, 14(3), 841; https://doi.org/10.3390/cancers14030841
Action Date Notes Link
article xml file uploaded 8 February 2022 10:45 CET Original file -
article xml uploaded. 8 February 2022 10:45 CET Update https://www.mdpi.com/2072-6694/14/3/841/xml
article pdf uploaded. 8 February 2022 10:45 CET Version of Record https://www.mdpi.com/2072-6694/14/3/841/pdf
article supplementary file uploaded. 8 February 2022 10:45 CET - https://www.mdpi.com/2072-6694/14/3/841#supplementary
article html file updated 8 February 2022 10:46 CET Original file -
article html file updated 31 July 2022 12:09 CEST Update https://www.mdpi.com/2072-6694/14/3/841/html
Back to TopTop